Vectorious
Strategic investment
Worked with the team to give Vectorious’s evolving plans a coherent, tangible form at each stage of the strategic-investment process.
What happens to the heart between clinic visits? In heart failure, rising pressure can signal trouble before symptoms do.
A miniature implant makes those changes visible—connecting daily life with physician-guided care.
Vectorious, acquired by Edwards Lifesciences in 2025, develops V-LAP, an investigational platform that measures pressure inside the heart to support heart-failure care.
vectoriousmedtech.com



